Tynixa Workspace
Reviewer workflowDraft-onlyHuman review required

Reviewer Mode

Review a draft package, mark evidence status, prepare reviewer decision, and continue to lab-director sign-off. This page keeps no final diagnosis and no final ACMG classification locked behind qualified human review.

Back to DashboardOpen Sign-off Queue

Package context

Reviewer decision

Reviewer workspace result

Load a package, create a demo package, or load the review queue.

Advanced technical audit JSON
No technical result yet.

Reviewer mode

What this page does

Review a package, request more evidence, or route the package for director sign-off.

Who should use it

Qualified reviewers and lab directors participating in governed review workflows.

What you get

Package summary actions, reviewer decisions, evidence request options, and sign-off routing.

What is not allowed

Reviewer mode does not bypass finalization controls or release reports without required approval.

Example in practice

A reviewer flags missing segregation evidence and routes the package back for additional review.

Next step

Load a package, record a review decision, request evidence, or continue to sign-off.

Reviewer value moments

Reviewer mode converts a package into a controlled decision path instead of an ungoverned AI output.

Evidence Request

Reviewers can request more evidence before escalation.

Basis: review decision actions

Director Route

Ready cases can be routed to lab director review.

Basis: sign-off workflow link

Audit Continuity

The review path keeps package context and decision boundaries visible.

Basis: review queue and package context

Safety: These value moments are event-based and review-context-only. They do not claim autonomous diagnosis, final ACMG classification, treatment decisions, clinical performance approval, regulatory approval, unsupervised clinical automation, same-visit final clinical decisions, or clinical release without qualified human sign-off.